Monika Richter focuses her practice on the biotechnology and pharmaceuticals sector. She advises national and international clients on various legal matters related to the development and partnering of pharmaceutical compounds and products, with a particular focus on strategic alliances, license agreements, research collaborations and co-development agreements. Her work likewise includes financing and corporate transactions as well as mergers and acquisitions.
Given her Polish background, Monika is active in the Eastern European market, regularly speaking at industry conferences in Poland and advising Polish clients on several cross-border collaborations in the life sciences sector.
Prior to joining McDermott, Monika has worked for other international law firms in Berlin and Frankfurt.
Advised Paion, a German biotechnology company, on a licensing transaction with a global pharmaceutical company regarding local rights in its asset Remimazolam*
Advised Selvita, one of Poland’s largest biotechnology companies, on various international licensing and collaboration agreements, including with Orion Pharma, H3, Felicitex, Merck KGaA, Menarini and on a funding agreement with the Leukemia and Lymphoma Society*
Advised a big Polish pharmaceutical company on a research collaboration with a German pharmaceutical company*
Advised uniQure on a commercialization agreement for Glybera, the first gene therapy product approved in the EU, with Chiesi and on an exclusive strategic collaboration with Bristol-Myers Squibb*
Advised several biotechnology companies on multinational bidder transactions directed to licensing agreements with local partners, most recently a US pharmaceutical company on a multinational licensing transaction regarding local rights for a dermatological assets with partners in China, Japan, India and US*
Advised several biotechnology companies on research and collaboration agreements and IP transfer agreements with universities/university clinics in Germany and other countries of the world*
Do not send any information or documents that you want to have treated as secret or confidential. Providing information to McDermott via email links on this website or other introductory email communications will not create an attorney-client relationship; will not preclude McDermott from representing any other person or firm in any matter; and will not obligate McDermott to keep confidential the information you provide. McDermott cannot enter into an attorney-client relationship with you until McDermott has determined that doing so will not create a conflict of interest and until you and McDermott have entered into a written agreement or engagement letter that sets forth the terms of our relationship.